Detection and treatment of subclinical tuberculosis.

Tuberculosis (Edinburgh, Scotland), Volume: 92, Issue: 6
November 21, 2012
Brian D Robertson BD, Danny Altmann D, Clif Barry C, Bill Bishai B, Stewart Cole S, Thomas Dick T, Ken Duncan K, Chris Dye C, Sabine Ehrt S, Hanif Esmail H, Joanne Flynn J, Richard Hafner R, Gray Handley G, Willem Hanekom W, Paul van Helden P, Gilla Kaplan G, Stefan H E Kaufmann SH, Peter Kim P, Christian Lienhardt C, Valerie Mizrahi V, Eric Rubin E, Dirk Schnappinger D, David Sherman D, Jelle Thole J, Omar Vandal O, Gerhard Walzl G, Digby Warner D, Robert Wilkinson R, Douglas Young D

Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.

Courtesy of the U.S. National Library of Medicine